Last reviewed · How we verify
DOX: Docetaxel, oxaliplatin, Capecitabine
DOX: Docetaxel, oxaliplatin, Capecitabine is a Small molecule drug developed by Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). It is currently in Phase 2 development.
At a glance
| Generic name | DOX: Docetaxel, oxaliplatin, Capecitabine |
|---|---|
| Sponsor | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma (PHASE2, PHASE3)
- Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer (PHASE2)
- Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study (PHASE2)
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS) (PHASE3)
- Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer (PHASE2)
- Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer (PHASE3)
- Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma (PHASE2)
- Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DOX: Docetaxel, oxaliplatin, Capecitabine CI brief — competitive landscape report
- DOX: Docetaxel, oxaliplatin, Capecitabine updates RSS · CI watch RSS
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) portfolio CI
Frequently asked questions about DOX: Docetaxel, oxaliplatin, Capecitabine
What is DOX: Docetaxel, oxaliplatin, Capecitabine?
DOX: Docetaxel, oxaliplatin, Capecitabine is a Small molecule drug developed by Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Who makes DOX: Docetaxel, oxaliplatin, Capecitabine?
DOX: Docetaxel, oxaliplatin, Capecitabine is developed by Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) (see full Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) pipeline at /company/spanish-cooperative-group-for-the-treatment-of-digestive-tumours-ttd).
What development phase is DOX: Docetaxel, oxaliplatin, Capecitabine in?
DOX: Docetaxel, oxaliplatin, Capecitabine is in Phase 2.